Patents by Inventor Richard N. Ushijima

Richard N. Ushijima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10842819
    Abstract: Provided are methods for treating itching caused by allergy, include itching associated with parasite-mediated inflammation (e.g., demodicosis, stomatitis, dermatophytosis, etc.), comprising administration to a mammalian subject in need thereof a therapeutically effective amount of a heat-treated, fractionated thymus extract composition (e.g., Thyex-1-6A and -6B compositions, comprising proteins or polypeptides having molecular weights in the range of 3.5 kDa to 30 kDa), in combination with or formulated with colostrum, to provide for reducing itching in the subject. Combination or adjunctive therapies comprising administration of a heat-treated, fractionated thymus extract composition in combination with or formulated with colostrum, and including at least one additional anti-parasitic, anti-bacterial, anti-fungal, anti-viral agent, or homeopathic agent are also provided.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: November 24, 2020
    Assignee: CMI Research Management, LLC
    Inventors: Ryan Ushijima, Richard N. Ushijima
  • Publication number: 20170035810
    Abstract: Provided are methods for treating itching caused by allergy, include itching associated with parasite-mediated inflammation (e.g., demodicosis, stomatitis, dermatophytosis, etc.), comprising administration to a mammalian subject in need thereof a therapeutically effective amount of a heat-treated, fractionated thymus extract composition (e.g., Thyex-1-6A and -6B compositions, comprising proteins or polypeptides having molecular weights in the range of 3.5 kDa to 30 kDa), in combination with or formulated with colostrum, to provide for reducing itching in the subject. Combination or adjunctive therapies comprising administration of a heat-treated, fractionated thymus extract composition in combination with or formulated with colostrum, and including at least one additional anti-parasitic, anti-bacterial, anti-fungal, anti-viral agent, or homeopathic agent are also provided.
    Type: Application
    Filed: July 8, 2016
    Publication date: February 9, 2017
    Inventors: Ryan Ushijima, Richard N. Ushijima
  • Patent number: 9050314
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to arthritis and/or arthritis-related conditions, including: gout, rheumatoid arthritis (RA), osteoarthritis (OA), and pseudogout, and/or inflammation resulting from any of the conditions Additional aspects provide methods for combination or adjunctive therapies (with anti-inflammatories, etc.). Methods to modulate immune response are also encompassed.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: June 9, 2015
    Assignee: CMI Research Management, LLC
    Inventor: Richard N. Ushijima
  • Patent number: 9006401
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of Houttuynia cordata extracts and the use of those extracts as an anti-emetic and/or anti-nausea treatment for a subject in need thereof.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: April 14, 2015
    Assignee: CMI Research Management, LLC
    Inventor: Richard N. Ushijima
  • Publication number: 20140072651
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of Houttuynia cordata extracts and the use of those extracts as an anti-emetic and/or anti-nausea treatment for a subject in need thereof.
    Type: Application
    Filed: November 14, 2013
    Publication date: March 13, 2014
    Applicant: CMI Research Management, LLC
    Inventor: Richard N. Ushijima
  • Patent number: 8609824
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of Houttuynia cordata extracts and the use of those extracts as an anti-emetic and/or anti-nausea treatment for a subject in need thereof.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: December 17, 2013
    Assignee: CMI Research Management, LLC
    Inventor: Richard N. Ushijima
  • Publication number: 20120164076
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to cancer. In preferred synergistic aspects, the inventive compositions (Thyex-1-6A and -6B) are administered in combination with a macrophage stimulating agent (e.g., beta glucan) for cancer treatment. Certain aspects relate to treating cancer, comprising: administering of a therapeutically effective amount of a thymus extract composition (Thyex-1-6A and -6B) in combination with administration of an extract of Houttuynia cordata. Further aspects comprise administration to a mammalian subject in need thereof a therapeutically effective amount of an extract of Houttuynia cordata, wherein treating or alleviating nausea is afforded. Combination or adjunctive therapies (e.
    Type: Application
    Filed: July 2, 2010
    Publication date: June 28, 2012
    Applicant: CMI RESEARCH MANAGEMENT, LLC
    Inventor: Richard N. Ushijima
  • Publication number: 20110020465
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to arthritis and/or arthritis-related conditions, including: gout, rheumatoid arthritis (RA), osteoarthritis (OA), and pseudogout, and/or inflammation resulting from any of the conditions Additional aspects provide methods for combination or adjunctive therapies (with anti-inflammatories, etc.). Methods to modulate immune response are also encompassed.
    Type: Application
    Filed: July 2, 2010
    Publication date: January 27, 2011
    Applicant: CMI Research Management LLC
    Inventor: Richard N. Ushijima
  • Publication number: 20110020464
    Abstract: Embodiments of the present invention provide processes for preparing thymus extracts and plant or fungal extracts, and more particularly provide compositions (Thyex-1-6A and -6B) produced in accordance with said processes, and methods for treatment of various conditions comprising administration of said compositions including but not limited to impaired physical vigor or aptitude, and aging and/or age-related conditions (arthritis, mobility deficits, loss of appetite, etc.). Additional aspects provide methods for building muscle mass, for reducing exercise recovery period, or for sustaining exercise intensity. Particular aspects relate to preparation of Houttuynia cordata extracts and the use of those extracts as an anti-emetic and/or anti-nausea treatment for a subject in need thereof.
    Type: Application
    Filed: July 2, 2010
    Publication date: January 27, 2011
    Inventor: Richard N. Ushijima
  • Patent number: 4394374
    Abstract: A process for the manufacture of a new thymus gland extract is disclosed. Comminuted thymus glands are mixed with hot distilled water which dissolves target protein substances. After a period of time, solids and liquid fats are separated from the aqueous solution. The solution is mixed with a large volume of a sulfate salt to form a pricipitate containing a high yield of the target substances.
    Type: Grant
    Filed: June 15, 1981
    Date of Patent: July 19, 1983
    Inventor: Richard N. Ushijima